Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 4 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Indonesia ramps up fight against tuberculosis amid concerns on economic impact
AOL· 16 minutes agoIndonesia plans to run clinical trials of several vaccines to fight surging cases of tuberculosis (TB) this year, with concerns the disease might affect economic growth, ministers ...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 1 day agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long ...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 1 day agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 4 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
F.D.A. Advisers Recommend a New Covid Vaccine Formula for the Fall
New York Times· 4 days agoA committee of advisers to the Food and Drug Administration voted on Wednesday to update the formula...
FDA Panel OKs New COVID Vaccine for Fall
Star City News· 4 days agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 5 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...